TY  - GEN
AU  - Gutierrez, Antonio
AU  - Rodriguez, Jose
AU  - Martinez-Serra, Jordi
AU  - Gines, Jordi
AU  - Paredes, Pilar
AU  - Garcia, Florencia
AU  - Vercher, Javier
AU  - Balanzat, Josep
AU  - del Campo Garcia, Raquel
AU  - Galan, Pilar
AU  - Morey, Miguel
AU  - Sampol Mayol, Antonia
AU  - Novo, Andrés
AU  - Bento, Leyre
AU  - Garcia, Lucia
AU  - Bargay Lleonart, Joan
AU  - Besalduch Vidal, Juan
PY  - 2014
DO  - 10.2147/OTT.S70264
SN  - 1178-6930
UR  - http://hdl.handle.net/20.500.12105/19955
AB  - Background: Most Hodgkin lymphomas (HL) can be cured with current strategies. However, one-third of the cases do not respond or relapse and need salvage regimens. We report the results of a retrospective study using the gemcitabine and oxaliplatinum...
LA  - eng
PB  - Dove Medical Press
KW  - Gemcitabine
KW  - Oxaliplatinum
KW  - GemOx
KW  - Hodgkin lymphoma
KW  - Treatment
TI  - Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma
TY  - research article
ER  -